Supported by a growing body of clinical evidence, medicinal cannabis is fast becoming recognised as a safe and effective treatment for a broad range of chronic conditions.

VentureCrowd CEO Steven Maarbani joins ticker NEWS to discuss our current investment offer, Aruma Labs, on the VentureCrowd platform and the growth outlook for the Australian medicinal cannabis industry.

You can invest in Aruma Labs here: https://bit.ly/3ENGpLm

——

Always consider the general CSF risk warning and offer document before investing.

source